Clinical Trial Update: Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating autologous mesenchymal stem cells for spinal cord injury, sponsored by Clínica Las Condes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Clínica Las Condes. LIT INNOVA CORFO | Conditions: Spinal Cord Injury | Phase 2 | Status: UNKNOWN